Showing 681-690 of 4110 results for "".
Hormonal Acne Treatment Options
https://practicaldermatology.com/conferences/maui-derm-2022/hormonal-acne-treatment-options/20053/All acne is hormonal acne, says Julie C. Harper, MD. She discusses her approach to treating acne in preadolescents, adolescents, and male and female patients. From the role of oral contraceptives for women to the new topical clascoterone option, she says there are a number of safe and effective treaRethink How You Market Your Practice During the Holidays
https://practicaldermatology.com/topics/practice-management/rethink-how-you-market-your-practice-during-the-holidays/23607/Winter can be the “gift that keeps on giving”—if you know how to leverage the season.Managing Patients with Atypical Nevi and Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/managing-patients-with-atypical-nevi-and-melanoma/19982/Monitoring patients with several atypical nevi who are at high risk for melanoma is very challenging. Steven Q. Wang, MD offers tips for improving diagnostic accuracy and discusses the role of dermoscopy in detecting melanoma as well as non-melanoma skin cancers at much earlier rates.New SEO Trends Dermatologists Should Anticipate in 2021
https://practicaldermatology.com/topics/practice-management/new-seo-trends-dermatologists-should-anticipate-in-2021/19900/Dermatology online marketing will have a surge of possible business in 2021 as people start moving back to requesting and seeking medical care again, especially once COVID-19 vaccines become widespread. Getting ahead of the SEO search curve now will give your office the advantage before the demand mDermWireTV: Candela + Merz Aesthetics Partnership, COVID-19 Vaccines & Fillers, Almirall's Klisyri, MetSyn & PsO
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-candela-merz-aesthetics-partnership-covid-19-vaccines-and-fillers-almiralls-klisyri-metsyn-and-pso/19893/Klisyri® (tirbanibulin) ointment 1% from Almirall will be available for treatment of AKs by the end of this quarter; Ayman Grada, MD discusses. Are patients who have received dermal filler injections at risk for developing reactions to the COVID-19 vaccine? Joel L. Cohen, MD and Doris Day, MD weighTroubleshooting teledermatology
https://practicaldermatology.com/topics/practice-management/troubleshooting-teledermatology/19854/Doctors and patients alike praise the ability of technology to enable virtual care, but this rapid transition has not been entirely trouble-free. In this video from Ekwa Marketing, we look at some of the most common problems, and how you might be able to avoid or solve them.DERM2020 NP/PA CME Conference Thank You from DEF President Joe Gorelick, MSN, FNP-C
https://practicaldermatology.com/conferences/dermatology-education-foundation-derm-2020/derm2020-nppa-cme-conference-thank-you/19837/Joe Gorelick thanks the participants for DERM2020 Session 1 – all live webinars from August 6 – 11, 2020!Scientifically Speaking: Botulinum Toxin Formulation and Testing
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-botulinum-toxin-formulation-and-testing/19832/Ever wonder about the differences in formulation and manufacture of botulinum neurotoxins? Curious about the trials that support approval? In this edition of Scientifically Speaking, Joel L. Cohen, MD gets the answers to these questions and more from Conor Gallagher, PhD, Head of Medical Affairs, ReEvolution in Dermatology/Industry Partnerships
https://practicaldermatology.com/topics/practice-management/evolution-in-dermatologyindustry-partnerships/23295/The COVID-19 crisis is changing the dermatology industry. What does it mean?Meet the Virtualist
https://practicaldermatology.com/topics/practice-management/meet-the-virtualist/23290/What will teledermatology look like in the post COVID-19 era?